AstraZeneca PLC Says European Patent for Symbicort to Treat Smokers Cough Revoked
LONDON: AstraZeneca PLC said Tuesday that a European patent covering the use of its Symbicort medicine as a treatment for a condition commonly known as "smoker's cough" has been revoked.